InsidersTradesSigma
GeoVax Labs, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)
Follow the GeoVax Labs, Inc. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Operating in the Health Care sector, GeoVax Labs, Inc. has recorded 19 reports. Market capitalisation: €7.7m. The latest transaction was disclosed on 11 April 2025 (Acquisition). Among the most active insiders: DODD DAVID A. Every trade is free.
19
Insider Decl.
0
Thresholds
€142,789
19 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate GeoVax Labs, Inc. Strong Buy (bullish), based on 3 analysts. Average price target: US$77.50.
60Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 11 April 2025
Declarations19 total
10,000 shares@ US$0.98100.0% of flowCommon StockSEC:0001437749-25-011750:0
Ideal exit: 5 Jan 2026 (T+270)
6,000 shares@ US$0.9987.1% of flowCommon StockSEC:0001437749-25-011658:0
Ideal exit: 5 Jan 2026 (T+270)
10,000 shares@ US$1.0816.0% of flowCommon StockSEC:0001437749-25-010482:0
Ideal exit: 27 Dec 2025 (T+270)
6,800 shares@ US$1.079931.9% of flowCommon StockSEC:0001437749-25-010179:0
Ideal exit: 26 Dec 2025 (T+270)
8,000 shares@ US$1.9522.9% of flowCommon StockSEC:0001437749-24-025953:0
Ideal exit: 6 May 2025 (T+270)
520 shares@ US$2.151.7% of flowCommon StockSEC:0001437749-24-005209:0
Ideal exit: 17 Nov 2024 (T+270)
2,000 shares@ US$2.7724.2% of flowCommon StockSEC:0001437749-24-003380:0
Ideal exit: 3 Nov 2024 (T+270)
6,944 shares@ US$0.3610.5% of flowCommon StockSEC:0001437749-23-035306:0
Ideal exit: 17 Sept 2024 (T+270)
9,653 shares@ US$0.5224.4% of flowCommon StockSEC:0001437749-23-026935:0
Ideal exit: 21 Jun 2024 (T+270)
35,087 shares@ US$0.5729.7% of flowCommon StockSEC:0001437749-23-024763:0
Ideal exit: 21 May 2024 (T+270)
10,000 shares@ US$0.517922.4% of flowCommon StockSEC:0001437749-23-024227:0
Ideal exit: 14 May 2024 (T+270)
32,000 shares@ US$0.638929.7% of flowCommon StockSEC:0001437749-23-011000:0
Ideal exit: 19 Jan 2024 (T+270)
8,000 shares@ US$0.6321.6% of flowCommon StockSEC:0001437749-23-010776:0
Ideal exit: 15 Jan 2024 (T+270)
10,000 shares@ US$1.1049.3% of flowCommon StockSEC:0001437749-22-022942:0
Ideal exit: 18 Jun 2023 (T+270)
1,000 shares@ US$0.8212.9% of flowCommon StockSEC:0001437749-22-016567:0
Ideal exit: 28 Mar 2023 (T+270)
4,464 shares@ US$1.120.062% mcap32.1% of flowCommon StockSEC:0001437749-22-016072:0
Ideal exit: 24 Mar 2023 (T+270)
10,000 shares@ US$1.210.15% mcap100.0% of flowCommon StockSEC:0001437749-22-015552:0
Ideal exit: 18 Mar 2023 (T+270)
9,722 shares@ US$0.720.087% mcap45.2% of flowCommon StockSEC:0001437749-22-011257:0
Ideal exit: 30 Jan 2023 (T+270)
4,999 shares@ US$0.710.044% mcap22.7% of flowCommon StockSEC:0001437749-22-011137:0
Ideal exit: 29 Jan 2023 (T+270)
19 of 19 declarations